Bayesian Capital Management’s MiMedx Group MDXG Stock Holding History

Bayesian Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.8K	Buy	+18,400	New	+$67.2K	0.05%	219
2024 Q3	–	Sell	-11,010	Closed	-$76.3K	–	907
2024 Q2	$76.3K	Buy	+11,010	New	+$77.4K	0.01%	660
2024 Q1	–	Sell	-10,319	Closed	-$90.5K	–	979
2023 Q4	$90.5K	Buy	+10,319	New	+$75.6K	0.01%	661
2022 Q3	–	Sell	-12,533	Closed	-$43K	–	900
2022 Q2	$43K	Buy	+12,533	New	+$49.1K	0.01%	719
2017 Q4	–	Sell	-10,500	Closed	-$125K	–	653
2017 Q3	$125K	Buy	+10,500	New	+$156K	0.03%	449
2017 Q1	–	Sell	-21,200	Closed	-$188K	–	586
2016 Q4	$188K	Buy	+21,200	New	+$190K	0.05%	533

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bayesian Capital Management's MDXG Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in MiMedx Group (MDXG) in Q2 2026: 18,400 shares worth $70.8K. The stake represents 0.05% of the portfolio and ranks #219 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in MDXG as recently as Q2 2024.

Bayesian Capital Management first reported a position in MDXG in Q4 2016 and has held it in 6 quarters since. The position peaked at $188K in Q4 2016. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Bayesian Capital Management held 18,400 shares of MiMedx Group worth $70.8K as of Q2 2026.
MiMedx Group was a new Bayesian Capital Management position in Q2 2026.
MiMedx Group made up 0.05% of Bayesian Capital Management's portfolio in Q2 2026, its #219 holding.
Bayesian Capital Management first reported a position in MiMedx Group in Q4 2016 and has held it in 6 quarters since.
Bayesian Capital Management's MiMedx Group position peaked at $188K in Q4 2016.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.